Article
One mutation, divergent journeys: expanding the clinical spectrum of homozygous SAMHD1 deficiency in childhood.
Rheumatology (Oxford, England) - 8 Jan 2026
Emreol Hülya Ercan, Ünal Dilara, Ayvaz Deniz Nazire Cagdas, Bilginer Yelda, Özen Seza
Abstract excerpt
OBJECTIVES: Homozygous loss-of-function mutations in SAMHD1 classically cause Aicardi-Goutières syndrome type 5 (AGS5), characterized by neuroinflammation and intracranial calcifications. Increasing evidence suggests a broader clinical spectrum. We aimed to describe the phenotypic heterogeneity associated with a single homozygous SAMHD1 variant in paediatric patients and to highlight diagnostic and therapeutic...
Topics
Join the communities discussing this publication.
